Latest News

 Filter by Provider

Dogecoin (CRYPTO: DOGE) and Shiba Inu

Intuitive Surgical (ISRG) shows strong growth momentum with 28% EPS growth and a bullish technical setup, offering a potential breakout opportunity.

Nvidia should continue to benefit from its early AI lead for years to come.

The Euro managed to fall below the support of 1.1665, which restored pressure on the market.

Buoyant economic growth and signs of recovering investment are paired with slowing wage dynamics, easing upside risks to the current disinflation trend.

Investors should be able to count on steady dividends from these great stocks.

Leidos Holdings has been outperforming the S&P 500 Index over the past year, and analysts remain fairly bullish about the stock’s prospects.

As Bitcoin (CRYPTO: BTC) is facing renewed pressure below the $90,000-mark, attention is turning to several Bitcoin-linked stocks showing a significant weakening in mo

Discover Rigel Pharmaceuticals (RIGL), a GARP stock with explosive growth, a low P/E ratio, and strong financials, offering value in the biotech sector.

Faraday Future Intelligent Electric Inc. shared a weekly business update from YT Jia, Founder and Global Co-CEO of FF.

Running behind doesn't mean you won't be ready. Begin by making small changes.

Cardano's price performance doesn't reflect the strides its ecosystem is taking.

The next phase of investing in AI is to look for companies that are successfully using AI to enhance the value of their offerings to customers.

Ming-Chi Kuo, a prominent tech analyst, has weighed in on the recent financial results of NVIDIA Corporation (NASDAQ: NVDA) and debunked myths of "fraud" surrounding its metrics.

Discover how ASA Gold and Precious Metals exemplifies the CANSLIM strategy with explosive 209% EPS growth, strong technicals, and leadership in its sector.

Gold price analysis suggests a consolidation near $4,050 amid dollar strength and geopolitics.

A recent Reuters report claimed that Meta earned a substantial portion of its revenue from fraudulent or banned ads.

Quantum computing isn't quite ready for prime time, and high-flying companies are very unprofitable.

Eli Lilly fell while Biogen jumped.

Read inspirational quotes about feeling appreciation, believing in yourself and setting lofty goals and striving.

Earnings season is starting to die down a little, which may come as a relief for some after last week’s market carnage. This week, we only have a few key companies reporting including Alibaba, Zscaler, Deer & Company and Dell Technologies.

This stock has more than tripled in 2025 alone and has some massive growth catalysts ahead.

The AI megatrend is benefiting Taiwan Semiconductor in a big way.

WTI crude oil prices fell more than 2% to $57.5 per barrel, hitting a one‑month low.

AVT03 will be commercialised in Europe in partnerships with STADA Arzneimittel AG and Dr. Reddy’s, the company said.

Shares are up 16% this year, beating the overall market.

The company said that it is discontinuing the trials.

Although Jack Henry & Associates has underperformed the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

Philippe Laffont is renowned for being an early investor in several of the world's most disruptive and prominent tech giants.

With dropping expectations and only somewhat improving current assessment, the November Ifo index suggests that the German economy remains deeply stuck in stagnation at year-end.

Discover SharkNinja (SN), an affordable growth stock with strong revenue, solid profits, and a reasonable valuation for long-term potential.

Why further downside may still be ahead for the shares of Universal Technical Institute even after a sharp 20% drop.

WeRide reported a Q3 revenue of RMB 171.0 million ($24.06 million), a 144% year-over-year increase.

Diginex stock rallies after signing MOU to acquire The Remedy Project, providing solutions for global supply chains.

The company said that 25 patients have been treated with Temferon as of November 21, and 44% of glioblastoma multiforme patients have reached 18-month survival.

Avery Dennison has substantially lagged behind the broader market over the past year, yet analysts remain moderately bullish on the stock’s prospects.

According to a Bloomberg News report, Wilson reiterated his bullish outlook for next year.

Axon Enterprise has significantly underperformed the broader market over the past year, yet analysts remain strongly bullish on the stock’s prospects.